Serum Institute of India’s coronavirus vaccine Covovax is now accessible for kids throughout the nation, firm CEO Adar Poonawalla mentioned on Tuesday.
In a submit on Twitter, he mentioned Covovax, which has been developed by Novavax, “is now available for children in India”.
He additional mentioned, “This is the only vaccine manufactured in India that is also sold in Europe and has an efficacy of > (more than) 90%.” This is in step with Prime Minister Narendra Modi’s “vision of providing yet another vaccine to protect our children”, Poonawalla mentioned.
Official sources on Monday had mentioned kids aged 12 to 17 years may henceforth now get the Covovax at non-public centres with a dose costing Rs 900 plus GST, along with hospital service cost of Rs 150.
The transfer adopted the advice of the National Technical Advisory Group on Immunisation (NTAGI) that the COVID-19 jab will be administered within the age group of 12-17 years.
India’s drug regulator had authorized Covovax for restricted use in emergency conditions in adults on December 28 final 12 months and within the 12-17 age group, topic to sure circumstances, on March 9.
Currently, kids aged 12 to 14 years are vaccinated with Biological E’s intramuscular vaccine Corbevax, whereas these within the 15-18 age group are being administered Bharat Biotech’s Covaxin at authorities vaccination centres.
Source: www.financialexpress.com”